Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease

Inhaled treprostinil is approved for the treatment of pulmonary hypertension-associated interstitial lung disease (PH-ILD); however, it has not shown significant benefit in patients with a pulmonary vascular resistance (PVR) < 4 WU. As such, treatment for non-severe PH-ILD remains controversial. A t...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Raj Parikh, Chebly Dagher, Harrison W. Farber
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2025-07-01
Цуврал:	Life
Нөхцлүүд:	level 3 cardiopulmonary exercise testing group 3 pulmonary hypertension pulmonary hypertension interstitial lung disease pulmonary vascular resistance treprostinil
Онлайн хандалт:	https://www.mdpi.com/2075-1729/15/7/1089
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!